Access here alternative investment news about Xeraya Capital-backed Intervenn Biosciences Raises $34M In Series B Round
Venture Capital

Xeraya Capital-backed Intervenn Biosciences Raises $34M In Series B Round

by dealstreetasia.com posted 1week ago 33 views
Last week, Xeraya announced its participation in Congenica's Series C round. The post Xeraya Capital-backed InterVenn Biosciences raises $34m in Series B round appeared first on DealStreetAsia.

In this article